Ominous sign of a disfiguring disease. Leprosy (Hansen's disease).
Winter
C A
CA
Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA.
Hsu
S
S
D000328:Adult; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000145:classification / Q000473:pathology; D015441:Leprosy, Tuberculoid / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D012293:Rifampin / Q000627:therapeutic use; D014481:United States; D014744:Vietnam / Q000208:ethnology
D007917:Leprostatic Agents; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin